Publication Information

{'id': 'https://openalex.org/W1501522216', 'doi': 'https://doi.org/10.1002/cpdd.106', 'title': 'Piroxicam immediate release formulations: A fasting randomized open‐label crossover bioequivalence study in healthy volunteers', 'display_name': 'Piroxicam immediate release formulations: A fasting randomized open‐label crossover bioequivalence study in healthy volunteers', 'publication_year': 2014, 'publication_date': '2014-02-09', 'ids': {'openalex': 'https://openalex.org/W1501522216', 'doi': 'https://doi.org/10.1002/cpdd.106', 'mag': '1501522216', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27129120'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/cpdd.106', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764863641', 'display_name': 'Clinical Pharmacology in Drug Development', 'issn_l': '2160-763X', 'issn': ['2160-763X', '2160-7648'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5039993763', 'display_name': 'Sally A. Helmy', 'orcid': 'https://orcid.org/0000-0003-0582-4722'}, 'institutions': [{'id': 'https://openalex.org/I169744251', 'display_name': 'Damanhour University', 'ror': 'https://ror.org/03svthf85', 'country_code': 'EG', 'type': 'education', 'lineage': ['https://openalex.org/I169744251']}], 'countries': ['EG'], 'is_corresponding': False, 'raw_author_name': 'Sally A. Helmy', 'raw_affiliation_strings': ['Department of Pharmaceutics, Faculty of Pharmacy; Damanhour University; Damanhour Egypt'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmaceutics, Faculty of Pharmacy; Damanhour University; Damanhour Egypt', 'institution_ids': ['https://openalex.org/I169744251']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5003858342', 'display_name': 'Heba M. El‐Bedaiwy', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I169744251', 'display_name': 'Damanhour University', 'ror': 'https://ror.org/03svthf85', 'country_code': 'EG', 'type': 'education', 'lineage': ['https://openalex.org/I169744251']}], 'countries': ['EG'], 'is_corresponding': False, 'raw_author_name': 'Heba M. El‐Bedaiwy', 'raw_affiliation_strings': ['Department of Pharmaceutics, Faculty of Pharmacy; Damanhour University; Damanhour Egypt'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmaceutics, Faculty of Pharmacy; Damanhour University; Damanhour Egypt', 'institution_ids': ['https://openalex.org/I169744251']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3450, 'currency': 'USD', 'value_usd': 3450, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.768456, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 79, 'max': 81}, 'biblio': {'volume': '3', 'issue': '6', 'first_page': '466', 'last_page': '471'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12547', 'display_name': 'Developmental Pharmacology in Pediatric Drug Use', 'score': 0.9987, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12547', 'display_name': 'Developmental Pharmacology in Pediatric Drug Use', 'score': 0.9987, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10375', 'display_name': 'Drug Metabolism and Pharmacogenomics', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11460', 'display_name': 'Green Analytical Chemistry in Pharmaceutical Analysis', 'score': 0.9962, 'subfield': {'id': 'https://openalex.org/subfields/1602', 'display_name': 'Analytical Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/bioequivalence', 'display_name': 'Bioequivalence', 'score': 0.9828278}, {'id': 'https://openalex.org/keywords/crossover-study', 'display_name': 'Crossover study', 'score': 0.7773857}, {'id': 'https://openalex.org/keywords/pharmaceutical-analysis', 'display_name': 'Pharmaceutical Analysis', 'score': 0.472707}, {'id': 'https://openalex.org/keywords/antipyretic', 'display_name': 'Antipyretic', 'score': 0.44017056}], 'concepts': [{'id': 'https://openalex.org/C42404028', 'wikidata': 'https://www.wikidata.org/wiki/Q864940', 'display_name': 'Bioequivalence', 'level': 3, 'score': 0.9828278}, {'id': 'https://openalex.org/C2778139025', 'wikidata': 'https://www.wikidata.org/wiki/Q408676', 'display_name': 'Piroxicam', 'level': 3, 'score': 0.895027}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8627888}, {'id': 'https://openalex.org/C87813604', 'wikidata': 'https://www.wikidata.org/wiki/Q1242899', 'display_name': 'Crossover study', 'level': 4, 'score': 0.7773857}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.7222283}, {'id': 'https://openalex.org/C44249647', 'wikidata': 'https://www.wikidata.org/wiki/Q208498', 'display_name': 'Confidence interval', 'level': 2, 'score': 0.6166757}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5103821}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.49955225}, {'id': 'https://openalex.org/C2779252780', 'wikidata': 'https://www.wikidata.org/wiki/Q582687', 'display_name': 'Antipyretic', 'level': 3, 'score': 0.44017056}, {'id': 'https://openalex.org/C181389837', 'wikidata': 'https://www.wikidata.org/wiki/Q461809', 'display_name': 'Bioavailability', 'level': 2, 'score': 0.42637104}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2948658}, {'id': 'https://openalex.org/C2780820201', 'wikidata': 'https://www.wikidata.org/wiki/Q173235', 'display_name': 'Analgesic', 'level': 2, 'score': 0.2801367}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.052114785}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000894', 'descriptor_name': 'Anti-Inflammatory Agents, Non-Steroidal', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D010894', 'descriptor_name': 'Piroxicam', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000894', 'descriptor_name': 'Anti-Inflammatory Agents, Non-Steroidal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000894', 'descriptor_name': 'Anti-Inflammatory Agents, Non-Steroidal', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D000894', 'descriptor_name': 'Anti-Inflammatory Agents, Non-Steroidal', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000894', 'descriptor_name': 'Anti-Inflammatory Agents, Non-Steroidal', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D019540', 'descriptor_name': 'Area Under Curve', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002214', 'descriptor_name': 'Capsules', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018592', 'descriptor_name': 'Cross-Over Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003692', 'descriptor_name': 'Delayed-Action Preparations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004339', 'descriptor_name': 'Drug Compounding', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004534', 'descriptor_name': 'Egypt', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005215', 'descriptor_name': 'Fasting', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005215', 'descriptor_name': 'Fasting', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D006207', 'descriptor_name': 'Half-Life', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D064368', 'descriptor_name': 'Healthy Volunteers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008657', 'descriptor_name': 'Metabolic Clearance Rate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008954', 'descriptor_name': 'Models, Biological', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010894', 'descriptor_name': 'Piroxicam', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010894', 'descriptor_name': 'Piroxicam', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D010894', 'descriptor_name': 'Piroxicam', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D010894', 'descriptor_name': 'Piroxicam', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013810', 'descriptor_name': 'Therapeutic Equivalency', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/cpdd.106', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764863641', 'display_name': 'Clinical Pharmacology in Drug Development', 'issn_l': '2160-763X', 'issn': ['2160-763X', '2160-7648'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27129120', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.76, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 14, 'referenced_works': ['https://openalex.org/W1481796766', 'https://openalex.org/W1981152419', 'https://openalex.org/W1983284883', 'https://openalex.org/W1987102234', 'https://openalex.org/W1994031506', 'https://openalex.org/W2020752021', 'https://openalex.org/W2036461504', 'https://openalex.org/W2037698344', 'https://openalex.org/W2053047209', 'https://openalex.org/W2083909596', 'https://openalex.org/W2111073558', 'https://openalex.org/W2165676555', 'https://openalex.org/W2502670554', 'https://openalex.org/W2732587568'], 'related_works': ['https://openalex.org/W813629418', 'https://openalex.org/W75050703', 'https://openalex.org/W4390261636', 'https://openalex.org/W4387296936', 'https://openalex.org/W3118969517', 'https://openalex.org/W2404987385', 'https://openalex.org/W2272263231', 'https://openalex.org/W2082768529', 'https://openalex.org/W2012695707', 'https://openalex.org/W1972730910'], 'abstract_inverted_index': {'Abstract': [0], 'Piroxicam': [1], 'is': [2], 'a': [3, 47, 57, 75, 95, 194], 'NSAID': [4], 'with': [5, 56, 104], 'analgesic': [6], 'and': [7, 98, 126, 153, 182, 198], 'antipyretic': [8], 'properties,': [9], 'used': [10], 'for': [11, 100, 139, 166], 'the': [12, 25, 140, 157, 162, 171, 180], 'treatment': [13], 'of': [14, 19, 27, 30, 60, 79, 84, 142, 146, 156, 184], 'rheumatoid': [15], 'diseases.': [16], 'The': [17, 39, 107, 135], 'aim': [18], 'this': [20], 'study': [21, 42, 55], 'was': [22, 43], 'to': [23, 46, 73], 'evaluate': [24], 'bioequivalence': [26], 'two': [28, 158, 172], 'brands': [29], 'piroxicam': [31, 101, 173, 197], 'capsules': [32], '(20': [33, 82], 'mg)': [34, 83], 'in': [35, 40], '24': [36, 66], 'Egyptian': [37], 'volunteers.': [38], 'vivo': [41], 'established': [44], 'according': [45], 'single‐center,': [48], 'randomized,': [49], 'single‐dose,': [50], 'laboratory‐blinded,': [51], '2‐period,': [52], '2‐sequence,': [53], 'crossover': [54], 'washout': [58], 'period': [59], '3': [61], 'weeks.': [62], 'Under': [63], 'fasting': [64], 'conditions,': [65], 'healthy': [67], 'male': [68], 'volunteers': [69], 'were': [70, 92, 129, 160, 175, 191, 201], 'randomly': [71], 'selected': [72], 'receive': [74], 'single': [76, 195], 'oral': [77], 'dose': [78], 'one': [80], 'capsule': [81], 'either': [85], 'test': [86], 'or': [87, 190], 'reference': [88], 'product.': [89], 'Plasma': [90], 'samples': [91], 'obtained': [93], 'over': [94], '144‐hour': [96], 'interval': [97], 'analyzed': [99], 'by': [102], 'HPLC': [103], 'UV': [105], 'detection.': [106], 'pharmacokinetic': [108], 'parameters': [109], 'C': [110, 147], 'max': [111, 114, 148], ',': [112, 115, 118, 121, 149, 152], 't': [113, 127], 'AUC': [116, 119, 150, 154], '0–t': [117, 151], '0–∞': [120, 155], 'V': [122], 'd': [123], '/F,': [124], 'Cl/F,': [125], '1/2': [128], 'determined': [130], 'from': [131], 'plasma': [132], 'concentration–time': [133], 'profiles.': [134], '90%': [136], 'confidence': [137], 'intervals': [138], 'ratio': [141], 'log': [143], 'transformed': [144], 'values': [145], 'treatments': [159], 'within': [161], 'acceptable': [163], 'range': [164], '(0.8–1.25)': [165], 'bioequivalence.': [167], 'From': [168], 'PK': [169], 'perspectives,': [170], 'formulations': [174, 200], 'considered': [176], 'bioequivalent,': [177], 'based': [178], 'on': [179], 'rate': [181], 'extent': [183], 'absorption.': [185], 'No': [186], 'adverse': [187], 'events': [188], 'occurred': [189], 'reported': [192], 'after': [193], '20‐mg': [196], 'both': [199], 'well‐tolerated.': [202]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1501522216', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}], 'updated_date': '2024-09-26T06:57:20.743291', 'created_date': '2016-06-24'}